New York (PRWEB) April 16, 2012

SunPeaks Ventures Extended its rally for a ninth straight session on Friday. Shares soared 4.05% to $ 1.80 after reaching a new high of $ 1.83 earlier in the session.

Members of StockReports.net were alerted by SMS several weeks ago. The shares have jumped 495% to $ 1.83 from $ 0.37 within a few weeks.

On Friday, SunPeaks Ventures announced their previous agreement with NBA Sports Team had culminated is an agreement to Launch Clotamin in 240 Walgreens throughout Arizona.

Find Out If Shares of SunPeaks Ventures Could break the $ 2 Barrier next week and if to expect a correction or a continued momentum by Reading The Free Trend Analysis Report here:

http://www.StockReports.net/stocks/SNPK

SEFE Incorporated Is gaining more and more attention as the potential stock to watch for 2012. Shares have been steadily gaining over the past three weeks. StockReports.net Issued an Alert with Shares trading at $ 0.80. So far the gains are near 65%.

However, considering the recent trend in SEFEs stock, Investors are wondering if there could be more momentum ahead

Find Out What StockReports.net has Learned About SEFE Incorporated and how it could affect the way this stock is traded.

http://www.StockReports.net/stocks/SEFE

WebSafety Inc. shares were up more than 30% on Friday. WebSafety is a leading provider of child-protection and parental-notification mobile phone solutions, announced today that the WebSafety AT&T retail-point of sale program has expanded into 109 Ohio AT&T authorized dealers.

The AT&T-WebSafetyTM official retail rollout will start in Michigan on May 1, 2012 and will be featured April 26th on Detroit’s Fox TV affiliate station http://www.myfoxdetroit.com.

Find Out How This News Could Propell Shares of WebSafety Higher By Reading The Free Trend Analysis Report. http://www.StockReports.net/stocks/ WBSI

Readen Holding Corp recently announced the launch and addition to its D5 Mobile B.V. subsidiary of the new Android Based Phones. News sent the shares up 50% on Friday on Volume of more than 800,000 shares. Reande Holding Corp. received a Strong Buy Recommendation from Barchart.com (http://barchart.com/quotes/stocks/RHCO).

StockReports.net Issued an SMS Alert on Thursday to VIP Members and has members reporting gains of over 50%.

Find Out How Shares of Readen Holding Corp could do Following the Barchart Recommendation by Reading the Free Trend Analysis Report. http://www.StockReports.net/stocks/ RHCO

American Energy Development Is An Independent Energy Company Engaging in the acquisition, exploration and development of oil and gas properties. The Company is currently receiving large investor awareness through a massive advertising campaign.

Find Out how this could affect the share price of American Energy Development by Reading the Free Trend Analysis Report. http://www.StockReports.net/stocks/ AEDC

About StockReports.net

StockReports.net is Owned and Operated by Investor Alley Inc, a full-service Financial Communications and Investor Relations Firm that specializes in maximizing investor awareness for micro-cap publicly traded companies.

StockReports.net issues momentum alerts on stocks that can provide gains to day traders.

StockReports.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% – 200% or more.

StockReports.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals StockReports.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the StockReport.net newsletter and receiving alerts from a Pro-Active team of researchers.

Stock Reports believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.StockReports.net

Disclosure: StockReports.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visitStockReports.net website, for complete risks and disclosures.

San Jose, California (PRWEB) April 20, 2012

Follow us on LinkedIn Over the years, hematology instruments and reagents has become an indispensable tool for diagnosis, and continues to maintain a strong position in global health. Currently, automated hematology systems play an important role in transfusion medicine, and facilitate the screening of blood donors and blood control product quality. Over the past year also saw the emergence of a new test for the CHR, CSF, CD61 and CD64. Over the next few years, sales of hematology reagents is expected to increase rapidly. Furthermore, the increase of laboratory automation, together with the importance of accreditation, is expected to stimulate demand even more. Another potential driver of growth include the increase in medical tourism, increasing the number of uninsured individuals, and employment prospects stronger emphasis on pre-employment test. Moreover, the industry overall health diagnostic tests, including hematology, promising significant potential for growth, supported by health reform carried out in various sectors in developed and emerging markets like India and China.

Hematology analysis

represent the segment of the market leaders in hematology instruments. The demand for hematology analysis is influenced by the development of alternative technologies, such as POC instruments and integrated analysis, advances in products and processes laboratory automation with high efficiency. The market was also affected by the shortage of qualified staff in the clinical laboratory, controlling cost pressures, the question of error reduction and revenue contributions from reagents and consumables. Companies invest large amounts on product development, and offers a more sophisticated, easy to use, precise and efficient system that meets the requirements of hospitals and clinical laboratories. The analysis is currently available for distributed multi-purpose laboratory, since the measurements hematological analyzed using a variety of different techniques.

United States led the global hematology instruments and reagents market. Replacement demand for analysis of hematology in the United States was largely affected by the consolidation of the laboratory, and a growing number of group purchasing organizations. Furthermore, the test volume contract because of the imposition of new standards. U.S. health care market has experienced an increase in the number of previous workshops, the medical office where doctors perform tests in-house. However, since adherence to regulatory guidelines, the number of laboratories has diminished and brought low demand for low-volume analysis. The growth in demand for hematology instruments and reagents are expected to come from the Asia-Pacific, Latin America and other emerging markets. In-vitro diagnostics market in Brazil, China and India has registered significant growth, due to increasing population, economic development, increased health care costs, and better access to private medical care. The third market should be an important driver for growth in vitro diagnostic products, including hematology instruments and reagents, which are supported by a strong technical capability fed by the countries.

hematology analyzer is an important segment of market instruments in hematology / coagulation, as stated by the new market research report on hematology instruments and reagents. Hematology analyzer for today is technologically advanced compared to traditional systems, developed twenty years ago. Companies invest large amounts on product development, and offers a more sophisticated, easy to use, precise and efficient system that meets the requirements of hospitals and clinical laboratories. Flow cytometry is a technique common in the developed world. However, the opportunities in developing countries where cytometry and image analysis is still

.

The global market for hematology instrument is obviously a special player. The competition in this market is based on several factors, including innovation, price, product, service, distribution and promotion strategies. Therefore, the scenario is essentially a call for significant investments in product research and innovation alliance and maintain a strategic competitive advantage. Sysmex, Beckman Coulter, and Abbott Laboratories is a major global market in hematology. Besides the three large companies, including several global market hematology smaller companies. Going forward, the market will likely see an influx of several new businesses, as reforms undertaken by the regions developed and developing, and low barriers to entry. Market, resultantly, will see increased competition as many new products from some of the company.

major players outlined in the report include Abbott Diagnostics Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Diagnostica Stago, Horiba Ltd., Instrumentation Laboratory Inc., Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Sysmex Corp., among others

.

research report titled “Hematology Instruments and Reagents: A Global Strategic Business Report” published by Global Industry Analysts Inc., provides a comprehensive overview of hematology instruments and reagents market, current market trends, key growth drivers , the innovation of new products / launch area recent activity, and profiles of leading participants and niche markets worldwide. The report provides annual sales estimates and projections for global hematology instruments and reagents market for the years 2009 through 2017 for the region, including the U.S., Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Key segments analyzed include Hematology / Coagulation Instruments (hematology analyzers, flow cytometers hematology analyzers, coagulation, Hemoglobinometers, stainers, centrifugal machine, Hematology and Hematology Vials), and Hematology / Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno – Hematology Reagents, Control plasma, Hematology Stains). This study also provides historical data for understanding the evolution of the market in the period 2003 to 2008.

For more details on the comprehensive report of market research, please visit
http://www.strategyr.com/Hematology_Instruments_And_Reagents_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people around the world. Each year, the GIA has published more than 1300 large-scale research reports and market analysis + 40.000 and technology trends, while the monitoring of over 126 000 companies around the world. With over 9500 customers in 27 countries, GIA is recognized as one of the largest and the famous market research.

Follow us on LinkedIn

Global Industry Analysts, Inc.

Phone: 408-528-9966

Fax: 408-528-9977

-mail: press (at) StrategyR (dot) com

Web Site: http://www.StrategyR.com/

clear = “all”
Find more domestic Press Release For Sale